Share

    


In This Section

Home / About / Awards & Recognition / Annual Achievement Award

Annual Achievement Award

The Annual Achievement Award has been given since 1980 to distinguished individuals or organizations in a wide variety of fields, who have reflected values of community cancer care through their outstanding contributions.

Nomination and Selection Process

Nominations are open now. To be considered by the Award Selection Committee for nomination for this award, please fill out the nomination form and submit it to Betsy Spruill, Member and Volunteer Engagement Manager, ACCC, by June 15, 2020.

The Award Selection Committee will review the applicants and nominees and select the candidate to recommend to the Board of Trustees for approval. The winner is then notified and recognized during the 37th National Oncology Conference in the fall.

Eligibility Criteria

  • Nominee must be able to accept the award during the National Oncology Conference.
  • Nominee MUST be a nationally recognized leader in cancer patient care.
  • Nominee will have made a national contribution in screening, prevention, and treatment; survivorship; patient advocacy; and/or laboratory science.

Award Winner Recognition

The Annual Achievement Award recipient is recognized during the ACCC National Oncology Conference in the fall. The winner receives the following:

  • $1,000 cash award plus a plaque
  • Travel expenses (TBD)
  • Conference registration fee waived
  • Featured in press release to local and national outlets
  • Acknowledgment through the ACCC website, electronic communications, and social media platforms
View Past Winners
Questions? Please email Betsy Spruill, Member and Volunteer Engagement Manager, ACCC, or call 301.984.9496, ext. 206.

2019 Annual Achievement Award Recipient

headshots-Hurria-Dale-200x500Arti Hurria, MD, FASCO
City of Hope

The 2019 ACCC Annual Achievement Award is being presented posthumously to Arti Hurria, MD, FASCO, former George Tsai Family Chair in Geriatric Oncology, director of the Center for Cancer and Aging at City of Hope, and nationally regarded expert and advocate for elderly patients with cancer.

In 1995, Dr. Hurria began her internship at Beth Israel Medical Center, which has a strong geriatrics and oncology programs. In addition, Dr. Hurria completed a geriatrics fellowship at Harvard to bolster her skills and knowledge in treating older patients before entering her oncology fellowship at Memorial Sloan Kettering Cancer Center (MSK) in 1999, a time when the field of geriatric oncology was just beginning to emerge. It was at MSK where Dr. Hurria met another important mentor, George Bosl, MD, who was Chair of Medicine. Together, they wrote a grant to bring cancer care and geriatrics together in a comprehensive cancer center. That experience solidified Dr. Hurria’s decision to enhance the field of geriatric oncology and influenced her move to City of Hope, where she made her mark in geriatric oncology and remained for the duration of her remarkable career.

Dr. Hurria served as founding editor of the Journal of Geriatric Oncology. She was Chair and Founder of the Cancer and Aging Research Group, Co-Chair of the Alliance Cancer in the Elderly Committee, past President of the International Society of Geriatric Oncology, and past Chair of the National Comprehensive Cancer Network® (NCCN®) Older Adult Oncology Committee. She received many awards and honors, including ASCO’s B. J. Kennedy Award for Scientific Excellence in Geriatric Oncology, the International Society of Geriatric Oncology’s Paul Calabresi award, the Paul B. Beeson Career Development Award in Aging (K23), and the Frederick Steen Memorial Award for Humanism in Medicine.

William Dale, MD, PhD, co-principal investigator with Dr. Hurria on a five-year, $2 million grant from the National Institute of Aging, will accept the award on her behalf. Dr. Dale, the Arthur M. Coppola Family Chair in Supportive Care Medicine and clinical professor and chair of City of Hope's Department of Supportive Care Medicine, will provide an update on their ground-breaking research and the importance of conducting a comprehensive geriatric assessment to help address the unique needs of this growing patient population.